Compounding Pharmacies and GLP-1 Medications The combination of high brand-name prices and documented shortages created a substantial market for compounded semaglutide and tirzepatide
Potential side effects may include injection site irritation, water retention, appetite changes, headaches, fatigue, dizziness, blood sugar changes, nausea, hormone imbalance, drug interactions, or unknown long-term effects
This leads to: More glucose remaining in circulation after meals More insulin release to compensate More energy stored as fat initially subcutaneous, but eventually as visceral fat As VAT accumulates, it drives inflammation, insulin resistance, and metabolic dysfunction creating a vicious cycle
Mitohormesis, or mitochondrial adaptive response, also plays a crucial role
More than 3 million people with Medicare could be eligible for the difficult-to-find and expensive weight-loss drug under new guidance which can cover the medication for patients who are obese or those who have a history of heart disease and are at risk of a heart attack or stroke
A growing number of Boomers looking to redline their retirements